{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:15:23Z","timestamp":1792656923609,"version":"4.5.0"},"reference-count":32,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T00:00:00Z","timestamp":1424736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2015,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Folliculitis decalvans leads to scarring alopecia through inflammatory destruction of the hair follicle. Currently, antibiotics are most commonly used to treat this disease. However, treatment regimens with antibiotics feature a high relapse rate and encourage the development of resistant bacteria.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate the outcome of different treatment options for folliculitis decalvans.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospective study to compare the efficacy of different treatment regimens in 28 patients with folliculitis decalvans.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The success of treatment with clindamycin and rifampicin, clarithromycin, dapsone and isotretinoin was analysed. The evaluation of the combination of clindamycin and rifampicin showed the lowest success rate in achieving long\u2010term remission, since 80% of the patients relapsed shortly after end of treatment. Clarithromycin and dapsone were more successful with long\u2010term and stable remission rates of 33% and 43% respectively. Treatment with isotretinoin was the most successful oral treatment in our analysis with 90% of the patients experiencing stable remission during and up to two years after cessation of the treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The common use of antibiotics as first\u2010line therapy in folliculitis decalvans needs to be re\u2010evaluated critically and oral isotretinoin should be considered as valid treatment alternative.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jdv.13052","type":"journal-article","created":{"date-parts":[[2015,2,25]],"date-time":"2015-02-25T04:27:27Z","timestamp":1424838447000},"page":"1816-1821","source":"Crossref","is-referenced-by-count":42,"title":["Oral isotretinoin as the most effective treatment in folliculitis decalvans: a retrospective comparison of different treatment regimens in 28 patients"],"prefix":"10.1111","volume":"29","author":[{"given":"J.K.","family":"Tietze","sequence":"first","affiliation":[{"name":"Department of Dermatology and Allergy Ludwig\u2010Maximilian University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.V.","family":"Heppt","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy Ludwig\u2010Maximilian University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"von Preu\u00dfen","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy Ludwig\u2010Maximilian University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy Ludwig\u2010Maximilian University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ruzicka","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy Ludwig\u2010Maximilian University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Wolff","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy Ludwig\u2010Maximilian University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.C.","family":"Sattler","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy Ludwig\u2010Maximilian University Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,2,24]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"809","article-title":"Folliculitis decalvans","volume":"23","author":"Little EG","year":"1930","journal-title":"Proc R Soc Med"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2008.00204.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02675.x"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02216.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-200606000-00051"},{"key":"e_1_2_6_7_1","first-page":"319","article-title":"Quinquad's folliculitis decalvans and tufted hair","volume":"121","author":"Offidani A","year":"1994","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_2_6_8_1","first-page":"1","article-title":"Retrospective review of folliculitis decalvans in 23 patients with course and treatment analysis of long\u2010standing cases","volume":"18","author":"Bunagan MJ","year":"2014","journal-title":"J Cutan Med Surg"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05212.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2011.00639.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03564.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2004.30344.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70374-3"},{"key":"e_1_2_6_14_1","first-page":"363","article-title":"Treatment of folliculitis decalvans with tyrosine","volume":"8","author":"Salinger D","year":"1999","journal-title":"Exp Dermatol"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0151-9638(04)93570-3"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2012.07972_suppl.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-7753.66908"},{"key":"e_1_2_6_18_1","first-page":"512","article-title":"Folliculitis decalvans\u2013response to rifampin","volume":"42","author":"Brozena SJ","year":"1988","journal-title":"Cutis"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2002.tb00246.x"},{"key":"e_1_2_6_20_1","first-page":"184","article-title":"Folliculitis decalvans of the scalp: response to triple therapy with isotretinoin, clindamycin, and prednisolone","volume":"15","author":"Gemmeke A","year":"2006","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04048.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2340\/0001555572143145","article-title":"Folliculitis decalvans. Long\u2010lasting response to combined therapy with fusidic acid and zinc","volume":"72","author":"Abeck D","year":"1992","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2143(99)90181-6"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2009.03439.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1309\/NG60Y7V0WNUFH4LA"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2001.00746.x"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001050100273"},{"key":"e_1_2_6_28_1","first-page":"84","article-title":"Folliculitis decalvans\u2013a retrospective study in a tertiary referred centre, over five years","volume":"44","author":"Chandrawansa PH","year":"2003","journal-title":"Singapore Med J"},{"key":"e_1_2_6_29_1","first-page":"216","article-title":"Folliculitis decalvans in a family","volume":"66","author":"Jaiswal AK","year":"2000","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-9-200705010-00009"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03616.x"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700418"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.111"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.13052","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.13052","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.13052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T18:13:12Z","timestamp":1695492792000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.13052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,24]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.1111\/jdv.13052"],"URL":"https:\/\/doi.org\/10.1111\/jdv.13052","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,24]]}}}